Shopping Cart 0
Cart Subtotal
USD 0

United Kingdom Orthobiologics Market Outlook to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 9990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 14985

Details

United Kingdom Orthobiologics Market Outlook to 2025

Summary

GlobalData's new report, United Kingdom Orthobiologics Market Outlook to 2025, provides key market data on the United Kingdom Orthobiologics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories-Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Orthobiologics market categories-Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.

- 2017 company share and distribution share data for Orthobiologics market.

- Global corporate-level profiles of key companies operating within the United Kingdom Orthobiologics market.

- Key players covered include Medtronic plc, Sanofi, Stryker Corp and Others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 4

2.1 What Is This Report About? 4

2.2 OrthobiologicsMarket Segmentation 4

2.3 Definitions of Markets Covered in the Report 5

3 Orthobiologics Market, United Kingdom 8

3.1 Orthobiologics Market, United Kingdom, Revenue (USDm), 2015-2025 8

3.2 Orthobiologics Market, United Kingdom, Volume (Units), 2015-2025 20

3.3 Orthobiologics Market, United Kingdom, Average Price (USD), 2015-2025 32

3.4 Orthobiologics Market, United Kingdom, Distribution Share by Revenue (USDm), 2017 34

3.5 Orthobiologics Market, United Kingdom, Company Share by Revenue (USDm), 2017 35

4 Overview of Key Companies in United Kingdom, Orthobiologics Market 37

4.1 Medtronic Plc 37

4.2 Sanofi 37

4.3 DePuy Synthes Inc 37

4.4 Stryker Corp 37

4.5 Zimmer Biomet Holdings Inc 38

4.6 Fidia farmaceutici SpA 38

4.7 DJO Global Inc 38

4.8 Anika Therapeutics Inc 39

4.9 ConMed Corporation 39

4.10 Biocomposites Ltd 39

4.11 TRB Chemedica International SA 39

4.12 RTI Surgical Inc 40

4.13 Bioventus LLC 40

4.14 Orthofix Holdings Inc 40

5 Orthobiologics Market Pipeline Products 41

6 Financial Deals Landscape 43

6.1 Acquisition 43

6.2 Private Equity 45

7 Recent Developments 47

7.1 Corporate Communications 47

7.2 Financial Announcements 57

7.3 Other Significant Developments 66

7.4 Product News 72

8 Appendix 73

8.1 Research Methodology 74

8.2 GlobalData Consulting 78

8.3 Contact Us 79

8.4 Disclaimer 79


List Of Figure

1.2 List of Figures

Figure 1: Orthobiologics Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2025 10

Figure 2: Bone Grafts and Substitutes Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2025 13

Figure 3: Bone Growth Stimulators Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2025 16

Figure 4: Soft Tissue Biologics Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2025 18

Figure 5: Viscosupplementation Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2025 20

Figure 6: Orthobiologics Market, United Kingdom, Volume (Units), 2015-2025 22

Figure 7: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2015-2025 25

Figure 8: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2015-2025 28

Figure 9: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2015-2025 30

Figure 10: Viscosupplementation Market, United Kingdom, Volume (Units), 2015-2025 32

Figure 11: Orthobiologics Market, United Kingdom, Company Share (%) 2017 37


List Of Table

1.1 List of Tables

Table 1: Orthobiologics Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2020 11

Table 2: Orthobiologics Market, United Kingdom, Revenue (USDm), USD Constant, 2021-2025 12

Table 3: Bone Grafts and Substitutes Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2020 14

Table 4: Bone Grafts and Substitutes Market, United Kingdom, Revenue (USDm), USD Constant, 2021-2025 15

Table 5: Bone Growth Stimulators Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2020 17

Table 6: Bone Growth Stimulators Market, United Kingdom, Revenue (USDm), USD Constant, 2021-2025 17

Table 7: Soft Tissue Biologics Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2020 19

Table 8: Soft Tissue Biologics Market, United Kingdom, Revenue (USDm), USD Constant, 2021-2025 19

Table 9: Viscosupplementation Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2020 21

Table 10: Viscosupplementation Market, United Kingdom, Revenue (USDm), USD Constant, 2021-2025 21

Table 11: Orthobiologics Market, United Kingdom, Volume (Units), 2015-2020 23

Table 12: Orthobiologics Market, United Kingdom, Volume (Units), 2021-2025 24

Table 13: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2015-2020 26

Table 14: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2021-2025 27

Table 15: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2015-2020 29

Table 16: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2021-2025 29

Table 17: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2015-2020 31

Table 18: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2021-2025 31

Table 19: Viscosupplementation Market, United Kingdom, Volume (Units), 2015-2020 33

Table 20: Viscosupplementation Market, United Kingdom, Volume (Units), 2021-2025 33

Table 21: Orthobiologics Market, United Kingdom, Average Price (USD), 2015-2020 34

Table 22: Orthobiologics Market, United Kingdom, Average Price (USD), 2021-2025 35

Table 23: Orthobiologics Market, United Kingdom, Distribution Share by Revenue (USDm), USD Constant, 2017 36

Table 24: Orthobiologics Market, United Kingdom, Company Share by Revenue (USDm), USD Constant, 2017 38

Table 25: Orthobiologics Market Pipeline Products 43

Table 26: AK Medical to Acquire JRI Orthopaedics from Orthopaedic Research for USD23.6 Million 45

Table 27: Elliott Management May Acquire Stake in Smith & Nephew 47

Table 28: Saratoga Partners Acquires Orteq Sports Medicine 48

Table 29: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 78

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Orthopedic Devices, Arthroscopy Devices, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Orthobiologics, Orthopedic Bone Cement and Casting Materials, Orthopedic Power Tools, Orthopedic Prosthetics, Orthotic Devices, Other Joint Reconstruction, Spinal Surgery, Trauma Fixation, Value (USD), Volume (units), Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, DePuy Synthes Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Otto GmbH & Co KG, Medtronic plc, Smith & Nephew Plc, Ossur hf, Arthrex Inc, DJO Global Inc, e-life International Co., Ltd. Essity Aktiebolag


Companies

Medtronic Plc

Sanofi

DePuy Synthes Inc

Stryker Corp

Zimmer Biomet Holdings Inc

Fidia farmaceutici SpA

DJO Global Inc

Anika Therapeutics Inc

ConMed Corporation

Biocomposites Ltd

TRB Chemedica International SA

RTI Surgical Inc

Bioventus LLC

Orthofix Holdings Inc

Company Profile

Company Profile Title

United Kingdom Orthobiologics Market Outlook to 2025

Summary

GlobalData's new report, United Kingdom Orthobiologics Market Outlook to 2025, provides key market data on the United Kingdom Orthobiologics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories-Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Orthobiologics market categories-Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.

- 2017 company share and distribution share data for Orthobiologics market.

- Global corporate-level profiles of key companies operating within the United Kingdom Orthobiologics market.

- Key players covered include Medtronic plc, Sanofi, Stryker Corp and Others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 4

2.1 What Is This Report About? 4

2.2 OrthobiologicsMarket Segmentation 4

2.3 Definitions of Markets Covered in the Report 5

3 Orthobiologics Market, United Kingdom 8

3.1 Orthobiologics Market, United Kingdom, Revenue (USDm), 2015-2025 8

3.2 Orthobiologics Market, United Kingdom, Volume (Units), 2015-2025 20

3.3 Orthobiologics Market, United Kingdom, Average Price (USD), 2015-2025 32

3.4 Orthobiologics Market, United Kingdom, Distribution Share by Revenue (USDm), 2017 34

3.5 Orthobiologics Market, United Kingdom, Company Share by Revenue (USDm), 2017 35

4 Overview of Key Companies in United Kingdom, Orthobiologics Market 37

4.1 Medtronic Plc 37

4.2 Sanofi 37

4.3 DePuy Synthes Inc 37

4.4 Stryker Corp 37

4.5 Zimmer Biomet Holdings Inc 38

4.6 Fidia farmaceutici SpA 38

4.7 DJO Global Inc 38

4.8 Anika Therapeutics Inc 39

4.9 ConMed Corporation 39

4.10 Biocomposites Ltd 39

4.11 TRB Chemedica International SA 39

4.12 RTI Surgical Inc 40

4.13 Bioventus LLC 40

4.14 Orthofix Holdings Inc 40

5 Orthobiologics Market Pipeline Products 41

6 Financial Deals Landscape 43

6.1 Acquisition 43

6.2 Private Equity 45

7 Recent Developments 47

7.1 Corporate Communications 47

7.2 Financial Announcements 57

7.3 Other Significant Developments 66

7.4 Product News 72

8 Appendix 73

8.1 Research Methodology 74

8.2 GlobalData Consulting 78

8.3 Contact Us 79

8.4 Disclaimer 79


List Of Figure

1.2 List of Figures

Figure 1: Orthobiologics Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2025 10

Figure 2: Bone Grafts and Substitutes Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2025 13

Figure 3: Bone Growth Stimulators Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2025 16

Figure 4: Soft Tissue Biologics Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2025 18

Figure 5: Viscosupplementation Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2025 20

Figure 6: Orthobiologics Market, United Kingdom, Volume (Units), 2015-2025 22

Figure 7: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2015-2025 25

Figure 8: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2015-2025 28

Figure 9: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2015-2025 30

Figure 10: Viscosupplementation Market, United Kingdom, Volume (Units), 2015-2025 32

Figure 11: Orthobiologics Market, United Kingdom, Company Share (%) 2017 37


List Of Table

1.1 List of Tables

Table 1: Orthobiologics Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2020 11

Table 2: Orthobiologics Market, United Kingdom, Revenue (USDm), USD Constant, 2021-2025 12

Table 3: Bone Grafts and Substitutes Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2020 14

Table 4: Bone Grafts and Substitutes Market, United Kingdom, Revenue (USDm), USD Constant, 2021-2025 15

Table 5: Bone Growth Stimulators Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2020 17

Table 6: Bone Growth Stimulators Market, United Kingdom, Revenue (USDm), USD Constant, 2021-2025 17

Table 7: Soft Tissue Biologics Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2020 19

Table 8: Soft Tissue Biologics Market, United Kingdom, Revenue (USDm), USD Constant, 2021-2025 19

Table 9: Viscosupplementation Market, United Kingdom, Revenue (USDm), USD Constant, 2015-2020 21

Table 10: Viscosupplementation Market, United Kingdom, Revenue (USDm), USD Constant, 2021-2025 21

Table 11: Orthobiologics Market, United Kingdom, Volume (Units), 2015-2020 23

Table 12: Orthobiologics Market, United Kingdom, Volume (Units), 2021-2025 24

Table 13: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2015-2020 26

Table 14: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2021-2025 27

Table 15: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2015-2020 29

Table 16: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2021-2025 29

Table 17: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2015-2020 31

Table 18: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2021-2025 31

Table 19: Viscosupplementation Market, United Kingdom, Volume (Units), 2015-2020 33

Table 20: Viscosupplementation Market, United Kingdom, Volume (Units), 2021-2025 33

Table 21: Orthobiologics Market, United Kingdom, Average Price (USD), 2015-2020 34

Table 22: Orthobiologics Market, United Kingdom, Average Price (USD), 2021-2025 35

Table 23: Orthobiologics Market, United Kingdom, Distribution Share by Revenue (USDm), USD Constant, 2017 36

Table 24: Orthobiologics Market, United Kingdom, Company Share by Revenue (USDm), USD Constant, 2017 38

Table 25: Orthobiologics Market Pipeline Products 43

Table 26: AK Medical to Acquire JRI Orthopaedics from Orthopaedic Research for USD23.6 Million 45

Table 27: Elliott Management May Acquire Stake in Smith & Nephew 47

Table 28: Saratoga Partners Acquires Orteq Sports Medicine 48

Table 29: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 78

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Orthopedic Devices, Arthroscopy Devices, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Orthobiologics, Orthopedic Bone Cement and Casting Materials, Orthopedic Power Tools, Orthopedic Prosthetics, Orthotic Devices, Other Joint Reconstruction, Spinal Surgery, Trauma Fixation, Value (USD), Volume (units), Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, DePuy Synthes Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Otto GmbH & Co KG, Medtronic plc, Smith & Nephew Plc, Ossur hf, Arthrex Inc, DJO Global Inc, e-life International Co., Ltd. Essity Aktiebolag


Companies

Medtronic Plc

Sanofi

DePuy Synthes Inc

Stryker Corp

Zimmer Biomet Holdings Inc

Fidia farmaceutici SpA

DJO Global Inc

Anika Therapeutics Inc

ConMed Corporation

Biocomposites Ltd

TRB Chemedica International SA

RTI Surgical Inc

Bioventus LLC

Orthofix Holdings Inc